Journal of Molecular Modeling

, Volume 16, Issue 2, pp 311–326

Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: A molecular docking analysis

Original Paper

Abstract

A molecular docking investigation has been carried out on cytotoxic prenylated flavonoids from Lonchocarpus haberi with cancer-relevant chemotherapeutic targets known to be inhibited by flavonoids. Two molecular docking programs, Molegro and ArgusDock, were used to compare the binding energies of Lonchocarpus flavonoids with other flavonoids, inhibitors, or known ligands, to aromatase (CYP 19), fatty acid synthase (FAS), xanthine oxidase (XO), cyclooxygenases (COX-1 and COX-2), lipoxygenase (LOX-3), ornithine decarboxylase (ODC), protein tyrosine kinase (PTK), phosphoinositide 3-kinase (PI3K), protein kinase C (PKC), topoisomerase II (ATP binding site), ATP binding cassette (ABC) transporter, and phospholipase A2 (PLA). The Lonchocarpus flavonoids examined in this study exhibited docking energies comparable to or stronger than other flavonoids that had been previously shown to be effective inhibitors of these enzymes. Furthermore, prenylated flavonoids, such as the Lonchocarpus flavonoids and xanthohumol, generally showed greater binding energies than the non-prenylated flavonoids. We conclude, therefore, that the Lonchocarpus flavonoids possibly owe their cytotoxic activity by inhibition of one or more of these enzymes.

Figure

Prenylated flavonoids from Lonchocarpus haberi

Keywords

Cancer Flavonoids Lonchocarpus haberi Molecular docking 

References

  1. 1.
    American Cancer Society (2008) Cancer facts and figures. American Cancer Society, AtlantaGoogle Scholar
  2. 2.
    Jiang WH, Redfern A, Bryce RP, Mansel RE (2000) Prostaglandins Leukot Essent Fatty Acids 62:119–127Google Scholar
  3. 3.
    Nwankwo JO, Robbins ME (2001) Prostaglandins Leukot Essent Fatty Acids 64:241–245Google Scholar
  4. 4.
    Rusnak DW, Lackey K, Affleck K, Wood ER, Alligood KJ, Rhodes N, Keith BR, Murray DM, Knight WH, Mullin RJ, Gilmer TM (2001) Mol Cancer Ther 1:85–94Google Scholar
  5. 5.
    Rait AS, Pirollo KF, Rait V, Krygier JE, Xiang L, Chang EH (2001) Cancer Gene Ther 8:726–739Google Scholar
  6. 6.
    Bange J, Zwick E, Ullrich A (2001) Nat Med 7:548–552Google Scholar
  7. 7.
    Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA (2002) Cancer Res 62:1676–1681Google Scholar
  8. 8.
    Stoll BA (2002) Eur J Cancer Prev 11:319–325Google Scholar
  9. 9.
    Stoll BA (2002) Br J Nutr 87:193–198Google Scholar
  10. 10.
    Cristofanilli M, Hortobagyi GN (2002) Endocr Relat Cancer 9:249–266Google Scholar
  11. 11.
    Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP (2002) Clin Chem 48:1241–1250Google Scholar
  12. 12.
    Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R (2003) Oncogene 22:761–768Google Scholar
  13. 13.
    Imyantov EN, Hanson KP (2004) Drug Discov Today Dis Mech 1:235–245Google Scholar
  14. 14.
    Smith JA, Poteet-Smith CE, Xu Y, Errington TM, Hecht SM, Lannigan DA (2005) Cancer Res 65:1027–1034Google Scholar
  15. 15.
    Basu A (2008) Breast Cancer 2:11–16Google Scholar
  16. 16.
    Spiridon K (2006) Crit Rev Plant Sci 25:79–113Google Scholar
  17. 17.
    Gordaliza M (2007) Natural products as leads to anticancer drugs. Clin Translat Oncol 9:767–776Google Scholar
  18. 18.
    Middleton E (1996) Pharmaceut Biol 34:344–348Google Scholar
  19. 19.
    Harborne JB, Williams CA (2000) Phytochemistry 55:481–504Google Scholar
  20. 20.
    Middleton E, Kandaswami C, Theoharides TC (2000) Pharmacol Rev 52:673–751Google Scholar
  21. 21.
    Hodek P, Trefil P, Stiborová M (2002) Chem Biol Interact 139:1–21Google Scholar
  22. 22.
    Boumendjel A, Di Pietro A, Dumontet C, Barron D (2002) Med Res Rev 22:512–529Google Scholar
  23. 23.
    Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003) Med Res Rev 23:519–534Google Scholar
  24. 24.
    Brielmann H, Setzer WN, Kaufman PB, Kirakosyan A, Cseke LJ (2006) Phytochemicals: the chemical components of plants. In: Cseke LJ, Kirakosyan A, Kaufman PB, Warber SL, Duke JA, Brielmann HL (eds) Natural products from plants, 2nd edn. CRC, Boca Raton, pp 1–49Google Scholar
  25. 25.
    Waterman PG, Mahmoud EN (1987) Phytochem 26:1189–1193Google Scholar
  26. 26.
    Magalhães AF, Tozzi AMGA, Sales BHLN, Magalhães EG (1996) Phytochem 42:1459–1471Google Scholar
  27. 27.
    Magalhães AF, Ruiz ALTG, Tozzi AMGA, Magalhães EG (1999) Phytochem 52:1681–1685Google Scholar
  28. 28.
    Borges-Argáez R, Peña-Rodríguez LM, Waterman PG (2000) Phytochem 54:611–614Google Scholar
  29. 29.
    Magalhães AF, Tozzi AMA, Magalhães EG, Nogueira MA, Queiroz SCN (2000) Phytochem 55:787–792Google Scholar
  30. 30.
    Alavez-Solano D, Reyes-Chilpa R, Jiménez-Estrada M, Gómez-Garibay F, Chavez-Uribe I, Sousa-Sánchez M (2000) Phytochem 55:953–957Google Scholar
  31. 31.
    Pereira AS, Alfonso Serrano MA, Aquino Neto FR, Punha Pinto A, Purtado Texeira D, Gilbert B (2000) J Chromatogr Sci 38:174–180Google Scholar
  32. 32.
    Borges-Argáez R, Peña-Rodgríguez LM, Waterman PG (2002) Phytochem 60:533–540Google Scholar
  33. 33.
    Magalhães AF, Tozzi AMGA, Magalhães EG, Blanco IS, Soriano MdPC (2004) Ann Braz Acad Sci 76:651–661Google Scholar
  34. 34.
    Borges-Argáez R, Díaz MEP, Waterman PG, Peña-Rodríguez LM (2005) J Braz Chem Soc 16:1078–1081Google Scholar
  35. 35.
    Magalhães AF, Tozzi AMGA, Magalhães EG, Sannomiya M, Soriano MdPC, Perez MAF (2007) Ann Braz Acad Sci 79:351–367Google Scholar
  36. 36.
    Blatt CTT, Chávez D, Chai H, Graham JG, Cabieses F, Farnsworth NR, Cordell GA, Pezzuto JM, Kinghorn AD (2002) Phytother Res 16:320–325Google Scholar
  37. 37.
    Cunha GMdA, Fontenele JB, Júnior HVN, de Sousa FCM, Silveira ER, Nogueira NAP, de Moraes MO, Viana GSB, Costa-Lotufo LV (2003) Phytother Res 17:155–159Google Scholar
  38. 38.
    Borges-Argáez R, Bainbury L, Flowers A, Giménez-Turba A, Ruiz G, Waterman PG, Peña-Rodgríguez LM (2007) Phytomed 14:530–533Google Scholar
  39. 39.
    Brueggemeier RW, Hackett JC, Diaz-Cruz ES (2005) Endocr Rev 26:331–345Google Scholar
  40. 40.
    Sanderson JT, Hordijk J, Denison MS, Springsteel MF, Nantz MH, van den Berg M (2004) Toxicol Sci 82:70–79Google Scholar
  41. 41.
    Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA (2000) Proc Natl Acad Sci USA 97:3450–3454Google Scholar
  42. 42.
    Pizer ES, Jackisch C, Wood FD, Pasternack GR, Davidson NE, Kuhajda FP (1996) Cancer Res 56:2745–2747Google Scholar
  43. 43.
    Brusselmans K, Vrolix R, Verhoeven G, Swinnen JV (2005) J Biol Chem 280:5636–5645Google Scholar
  44. 44.
    Feig DI, Reid TM, Loeb LA (1994) Cancer Res 54:1890s–1894sGoogle Scholar
  45. 45.
    Storz P (2005) Front Biosci 10:1881–1896Google Scholar
  46. 46.
    Chang WS, Lee YJ, Lu FJ, Chiang HC (1993) Anticancer Res 13:2165–2170Google Scholar
  47. 47.
    Mutoh M, Takahashi M, Fukuda K, Komatsu H, Enya T, Matsushima-Hibiya Y, Mutoh H, Sugimura T, Wakabayashi K (2000) Jpn J Cancer Res 91:686–691Google Scholar
  48. 48.
    Kim HP, Mani I, Iversen L, Ziboh VA (1998) Prostaglandins Leukot Essent Fatty Acids 58:17–24Google Scholar
  49. 49.
    Marton LJ, Pegg AE (1995) Annu Rev Pharmacol Toxicol 35:55–91Google Scholar
  50. 50.
    Abrahamsen MS, Morris DR (1991) In: Pardee AB (ed) Perspectives on cellular regulation: from bacteria to cancer. Wiley, New York, pp 107–119Google Scholar
  51. 51.
    Auvinen M, Paasinen A, Andersson LA, Holtta E (1992) Nature 360:355–358Google Scholar
  52. 52.
    O’Brien TG, Megosh LC, Gilliard G, Soler AP (1997) Cancer Res 57:2630–2637Google Scholar
  53. 53.
    Mohan RR, Challa A, Gupta S, Bostwick DG, Ahmad N, Agarwal R, Marengo SR, Amini SB, Paras F, MacLennan GT, Resnick MI, Mukthtar H (1999) Clin Cancer Res 5:143–147Google Scholar
  54. 54.
    Clifford A, Morgan D, Yuspa SH, Soler AP, Gilmour S (1995) Cancer Res 55:1680–1686Google Scholar
  55. 55.
    Cañizares F, Salinas J, de las Heras M, Diaz J, Tovar I, Martinez P, Peñafiel R (1999) Clin Cancer Res 5:2035–2041Google Scholar
  56. 56.
    Kato R, Nakadate T, Yamamoto S, Sugimura T (1983) Carcinogenesis 4:1301–1305Google Scholar
  57. 57.
    Wei H, Tye L, Bresnick E, Birt DF (1990) Cancer Res 50:499–502Google Scholar
  58. 58.
    Kelloff GJ, Fay JR, Steele VE, Lubet RA, Boone CW, Crowell JA, Sigman CC (1996) Cancer Epidemiol Biomarkers Prev 5:657–666Google Scholar
  59. 59.
    Chang CJ, Geahlem RL (1992) J Nat Prod 55:1529–1560Google Scholar
  60. 60.
    Nishizuka Y (1986) Science 233:305–312Google Scholar
  61. 61.
    Ferriola PC, Cody V, Middleton E (1989) Biochem Pharmacol 15:1617–1624Google Scholar
  62. 62.
    Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rémésy C, Chap H, Payrastre B (1997) Biochem Pharmacol 53:1649–1657Google Scholar
  63. 63.
    Lin JK, Chen YC, Huang YT, Shiau SYL (1999) J Cell Biochem 67:S28–29, 39–48Google Scholar
  64. 64.
    Schlotter CM, Vogt U, Allgayer H, Brandt B (2008) Molecular targeted therapies for breast cancer treatment. Breast Cancer Res (http://breast-cancer-research.com/content/10/4/211)
  65. 65.
    Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, Payrastre B (1999) Gen Pharmacol 32:279–286Google Scholar
  66. 66.
    Williams RJ, Spencer JPE, Rice-Evans C (2004) Free Radic Biol Med 36:838–849Google Scholar
  67. 67.
    Melstrom LG, Salabat MR, Ding XZ, Milam BM, Strouch M, Pelling JC, Bentrem DJ (2008) Pancreas 37:426–431Google Scholar
  68. 68.
    Khan N, Afaq F, Syed DN, Mukhtar H (2008) Carcinogenesis 29:1049–1056Google Scholar
  69. 69.
    Harmon AW, Patel YM (2003) Biochem Biophys Res Commun 305:229–234Google Scholar
  70. 70.
    Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL (2000) Mol Cell 6:909–919Google Scholar
  71. 71.
    Pommier Y, Pourquier P, Fan Y, Strumberg D (1998) Biochim Biophys Acta 1400:83–105Google Scholar
  72. 72.
    Burden DA, Osheroff N (1998) Biochim Biophys Acta 1400:139–154Google Scholar
  73. 73.
    Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y (1988) Biochem Biophys Res Commun 157:183–189Google Scholar
  74. 74.
    Robinson MJ, Corbett AH, Osheroff N (1993) Biochem 32:3638–3643Google Scholar
  75. 75.
    Sharom FJ (2006) Biochem Cell Biol 84:979–992Google Scholar
  76. 76.
    Di Pietro A, Conseil G, Pérez-Victoria JM, Dayan G, Baubichon-Cortay H, Trompier D, Steinfels E, Jault JM, de Wet H, Maitrejean M, Comte G, Boumendjel A, Mariotte AM, Dumontet C, McIntosh DB, Goffeau A, Castanys S, Gamarro F, Barron D (2002) Cell Mol Life Sci 59:307–322Google Scholar
  77. 77.
    Di Pietro A, Dayan G, Conseil G, Steinfels E, Krell T, Trompier D, Baubichon-Cortay H, Jault J (1999) Braz J Med Biol Res 32:925–939Google Scholar
  78. 78.
    Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, Cole SP (2001) Mol Pharmacol 59:1171–1180Google Scholar
  79. 79.
    Yamashita S, Yamashita J, Ogawa M (1994) Br J Cancer 69:1166–1170Google Scholar
  80. 80.
    Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klären R, Gröne EF, Wiesel M, Güdemann C, Küster J, Schott W, Staehler G, Kretzler M, Hollstein H, Gröne HJ (2002) Am J Pathol 160:2169–2180Google Scholar
  81. 81.
    Guthridge CJ, Zimmer SG, Steiner MR (1995) Anticancer Res 15:1957–1962Google Scholar
  82. 82.
    Patel MI, Kurek C, Dong Q (2008) J Urol 179:1668–1675Google Scholar
  83. 83.
    Vogler B, Cholewa L, Schmidt J, Setzer W (2006) Pharmacologyonline 3:850–855Google Scholar
  84. 84.
    Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, Johnson EF (2007) J Biol Chem 282:14348–14355 (PDB: 2hi4)Google Scholar
  85. 85.
    Bell SG, Xu F, Forward I, Bartlam M, Rao Z, Wong LL (2008) J Mol Biol 383:561–574Google Scholar
  86. 86.
    Williams PA, Cosme J, Ward A, Angove HC, Matak Vinković D, Jhoti H (2003) Nature 424:464–468 (PDB: 1og5)Google Scholar
  87. 87.
    Williams PA, Cosme J, Sridhar V, Johnson EF, McRee D (2000) Molecular Cell 5:121–131 (PDB: 1dt6)Google Scholar
  88. 88.
    Favia AD, Cavalli A, Masetti M, Carotti A, Recanatini M (2006) Proteins 62:1074–1087 (PDB: 1tqa)Google Scholar
  89. 89.
    Ghosh D, Griswold J, Erman M, Pangborn W (2009) Nature 457:219–223 (PDB: 3eqm)Google Scholar
  90. 90.
    Chakravarty B, Gu Z, Chirala SS, Wakil SJ, Quiocho FA (2004) Proc Natl Acad Sci USA 101:15567–15572 (PDB: 1xkt)Google Scholar
  91. 91.
    Pemble CW, Johnson LC, Kridel SJ, Lowther WT (2007) Nat Struct Mol Biol 14:704–709 (PDB: 2px6)Google Scholar
  92. 92.
    Fukunari A, Okamoto K, Nishino T, Eger BT, Pai EF, Kamezawa M, Yamada I, Kato N (2004) J Pharmacol Exp Ther 311:519–528 (1vdv)Google Scholar
  93. 93.
    Enroth C, Eger BT, Okamoto K, Nishino T, Pai EF (2000) Proc Natl Acad Sci USA 97:10723–10728 (PDB: 1fo4)Google Scholar
  94. 94.
    Okamoto K, Eger BT, Nishino T, Kondo S, Pai EF, Nishino T (2003) An extremely potent inhibitor of xanthine oxidoreductase. J Biol Chem 278:1848–1855 (PDB: 1n5x)Google Scholar
  95. 95.
    Selinsky BS, Gupta K, Sharkey CT, Loll PJ (2001) Biochemistry 40:5172–5180 (PDB: 1eqg and 1eqh)Google Scholar
  96. 96.
    Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC (1996) Nature 384:644–648 (PDB: 3pgh and 4cox)Google Scholar
  97. 97.
    Skrzypczak-Jankun E, Zhou K, Jankun J (2003) Int J Mol Med 12:415–420 (PDB: 1jnq)Google Scholar
  98. 98.
    Borbulevych OY, Jankun J, Selman SH, Skrzypczak-Jankun E (2004) Proteins 54:13–19 (PDB: 1n8q)Google Scholar
  99. 99.
    Skrzypczak-Jankun E, Borbulevych OY, Jankun J (2004) Acta Crystallogr D60:613–615 (PDB: 1no3)Google Scholar
  100. 100.
    Almrud JJ, Oliveira MA, Kern AD, Grishin NV, Phillips MA, Hackert ML (2000) J Mol Biol 295:7–16 (PDB: 1d7k)Google Scholar
  101. 101.
    Dufe VT, Ingner D, Heby O, Khomutov AR, Persson L, Al-Karadaghi S (2007) Biochem J 405:261–268 (PDB: 2on3)Google Scholar
  102. 102.
    Stamos J, Sliwkowski MX, Eigenbrot C (2002) J Biol Chem 277:46265–46272 (PDB: 1m14 and 1m17)Google Scholar
  103. 103.
    Wood ER, Truesdale AT, McDonald OB, Yuan D, Hassell A, Dickerson SH, Ellis B, Pennisi C, Horne E, Lackey K, Alligood KJ, Rusnak DW, Gilmer TM, Shewchuk L (2004) Cancer Res 64:6652–6659 (PDB: 1xkk)Google Scholar
  104. 104.
    Messerschmidt A, Macieira S, Velarde M, Baedeker M, Benda C, Jestel A, Brandstetter H, Neuefeind T, Blaesse M (2005) J Mol Biol 352:918–931 (PDB: 1zrz)Google Scholar
  105. 105.
    Xu ZB, Chaudhary D, Olland S, Wolfrom S, Czerwinski R, Malakian K, Lin L, Stahl ML, Joseph-McCarthy D, Benander C, Fitz L, Greco R, Somers WS, Mosyak L (2004) J Biol Chem 279:50401–50409 (PDB: 1xjd)Google Scholar
  106. 106.
    Lamers MB, Antson AA, Hubbard RE, Scott RK, Williams DH (1999) J Mol Biol 285:713–725 (PDB: 1byg)Google Scholar
  107. 107.
    Gonzalez B, Schell MJ, Letcher AJ, Veprintsev DB, Irvine RF, Williams RL (2004) Mol Cell 15:689–701 (PDB: 1w2c and 1w2d)Google Scholar
  108. 108.
    Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL (2000) Mol Cell 6:909–919 (PDB: 1e8w, 1e90, 1e8y, and 1e8z)Google Scholar
  109. 109.
    Classen S, Olland S, Berger JM (2003) Proc Natl Acad Sci USA 100:10629–10634 (PDB: 1qzr)Google Scholar
  110. 110.
    Wei H, Ruthenburg AJ, Bechis SK, Verdine GL (2005) J Biol Chem 280:37041–37047 (PDB: 1zxm)Google Scholar
  111. 111.
    Yuan Y, Chen H, Patel D (to be published) (PDB: 1mv5)Google Scholar
  112. 112.
    Ramaen O, Leulliot N, Sizun C, Ulryck N, Pamlard O, Lallemand JY, Tilbeurgh H, Jacquet E (2006) J Mol Biol 359:940–949Google Scholar
  113. 113.
    Smith PC, Karpowich N, Millen L, Moody JE, Rosen J, Thomas PJ, Hunt JF (2002) Mol Cell 10:139–149Google Scholar
  114. 114.
    Chandra V, Jasti J, Kaur P, Betzel C, Srinivasan A, Singh TP (2002) J Mol Biol 320:215–222Google Scholar
  115. 115.
    Pan YH, Bahnson BJ (2007) J Mol Biol 369:439–450Google Scholar
  116. 116.
    Hansford KA, Reid RC, Clark CI, Tyndall JD, Whitehouse MW, Guthrie T, McGeary RP, Schafer K, Martin JL, Fairlie DP (2003) Chembiochem 4:181–185Google Scholar
  117. 117.
    Scott DL, White SP, Browning JL, Rosa JJ, Gelb MH, Sigler PB (1991) Science 254:1007–1010Google Scholar
  118. 118.
    Schevitz RW, Bach NJ, Carlson DG, Chirgadze NY, Clawson DK, Dilliard RD, Draheim SE, Hartley LW, Jones ND, Mihelich ED, Olkowski JL, Snyder DW, Sommers C, Wery JP (1995) Nat Struct Mol Biol 2:458–465Google Scholar
  119. 119.
    Wery JP, Schevitz RW, Clawson DK, Bobbitt JL, Dow ER, Gamboa G, Goodson T, Hermann RB, Kramer RM, McClure DB, Mihelich ED, Putnam JE, Sharp JD, Stark DH, Teater C, Warrick MW, Jones ND (1991) Nature 352:79–82Google Scholar
  120. 120.
    Molegro Virtual Docker 2.3 (2007) Molegro ApS. Aarhus, DenmarkGoogle Scholar
  121. 121.
    Thompsen R, Christensen MH (2006) J Med Chem 49:3315–3321Google Scholar
  122. 122.
    Thompson MA (2004) ArgusLab 4.0.1. Planaria Software LLC, SeattleGoogle Scholar
  123. 123.
    Paoletta S, Steventon GB, Wildeboer D, Ehrman TM, Hylands PJ, Barlow DJ (2008) Bioorg Med Chem 16:8466–8470Google Scholar
  124. 124.
    Wu CM, Wu SC, Chung WJ, Lin HC, Chen KT, Chen YC, Hsu MF, Yang JM, Wang JP, Lin CN (2007) Int J Mol Sci 8:830–841Google Scholar
  125. 125.
    Selvam C, Jackak SM, Oli RG, Thilagavathi R, Chakraborti AK, Bhutani KK (2004) Tetrahedron Lett 45:4311–4314Google Scholar
  126. 126.
    Maia F, Almeida MdR, Gales L, Kijjoa A, Pinto MMM, Saraiva MJ, Damas AM (2005) Biochem Pharmacol 70:1861–1869Google Scholar
  127. 127.
    Omar B, Mohamed N, Rahim RA, Wahab HA (2007) IFMBE Proc 14:178–182Google Scholar
  128. 128.
    Chang YC, Lee FW, Chen CS, Huang ST, Tsai SH, Huang SH, Lin CM (2007) Free Radic Biol Med 43:1541–1551Google Scholar
  129. 129.
    Lin HC, Tsai SH, Chen CS, Chang YC, Lee CM, Lai ZY, Lin CM (2008) Biochem Pharmacol 75:1416–1425Google Scholar
  130. 130.
    Badhan R, Penny J (2006) Eur J Med Chem 41:285–295Google Scholar
  131. 131.
    Boccard J, Bajot F, Di Pietro A, Rudaz S, Boumendjel A, Nicolle E, Carrupt PA (2009) Eur J Pharmaceut Sci 36:254–264Google Scholar
  132. 132.
    Wang Q, Ding ZH, Liu JK, Zheng YT (2004) Antiviral Res 64:189–194Google Scholar
  133. 133.
    Plochmann K, Korte G, Koutsilieri E, Richling E, Riederer P, Rethwilm A, Schreier P, Scheller C (2007) Arch Biochem Biophys 460:1–9Google Scholar
  134. 134.
    Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E (2007) Cancer Lett 246:201–209Google Scholar
  135. 135.
    Lee SG, Jun HJ, Lee JS, Lee IS, Kang BY (2007) Arch Pharm Res 30:1435–1439Google Scholar
  136. 136.
    Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF (2000) Molec Carcinogen 28:102–110Google Scholar
  137. 137.
    Chiang LC, Ng LT, Lin IC, Kuo PL, Lin CC (2006) Cancer Lett 237:207–214Google Scholar
  138. 138.
    Ujiki MB, Ding XZ, Salabat MR, Bentrem DJ, Golkar L, Milam B, Talamonti MS, Bell RH, Iwamura T, Adrian TE (2006) Mol Cancer 5:76Google Scholar
  139. 139.
    Chang H, Mi M, Ling W, Zhu J, Zhang Q, Wei N, Shou Y, Tang Y, Yuan J (2008) Arch Pharm Res 31:1137–1144Google Scholar
  140. 140.
    Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M (1999) Biosci Biotechnol Biochem 63:896–899Google Scholar
  141. 141.
    Hsu HF, Houng JY, Chang CL, Wu CC, Chang FR, Wu YC (2005) J Agric Food Chem 53:6117–6125Google Scholar
  142. 142.
    Sabzevari O, Galati G, Moridani MY, Siraki A, O’Brien PJ (2004) Chem Biol Interact 148:57–67Google Scholar
  143. 143.
    Forejtníková H, Lunerová K, Kubínová R, Jankovská D, Marek R, Kareš R, Suchý V, Vondráček J, Machala M (2005) Toxicol 208:81–93Google Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Department of ChemistryUniversity of Alabama in HuntsvilleHuntsvilleUSA

Personalised recommendations